The Effects of Exenatide Once Weekly (EXQW) and Exenatide Twice a Day (EXBID) on Beta-Cell Function in Type 2 Diabetes: A Systematic Review and Network Meta-Analysis
Background. In patients with type 2 diabetes mellitus (T2DM) and poor glycemic control receiving metformin (MET), glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are recommended as the adjunctive therapy. However, there are only a few studies involving the comparative effects of exenatide twic...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2019-01-01
|
| Series: | Journal of Diabetes Research |
| Online Access: | http://dx.doi.org/10.1155/2019/8083417 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832551025754505216 |
|---|---|
| author | Jie Wang Xinye Jin Ping An Songyan Yu Yiming Mu |
| author_facet | Jie Wang Xinye Jin Ping An Songyan Yu Yiming Mu |
| author_sort | Jie Wang |
| collection | DOAJ |
| description | Background. In patients with type 2 diabetes mellitus (T2DM) and poor glycemic control receiving metformin (MET), glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are recommended as the adjunctive therapy. However, there are only a few studies involving the comparative effects of exenatide twice a day (EXBID) and exenatide once weekly (EXQW) on HOMA-β. This meta assessed the comparative effects of EXQW and EXBID on HOMA-β among T2DM patients. Materials and Methods. PubMed, Cochrane Library, and Embase databases were searched to collect randomized controlled trials (RCTs). Network meta-analysis was performed, and network diagrams were constructed to evaluate the effects. The primary outcome is HOMA-β, and the secondary outcomes are fasting blood glycose (FBG), glycated hemoglobin (HbA1c), and weight loss. Results. A total of 8 studies with 3506 subjects were included. Compared with other antidiabetic agents, EXQW has a greater improvement in HOMA-β than EXBID (weight mean difference WMD=‐0.46, 95% confidence interval (CI) [-0.64, -0.28], P=0.001). The effect of EXQW on HbA1c is superior to that of sitagliptin (SITA) (WMD=0.51, 95% CI [0.03, 0.99], P=0.037). The significant reduction of weight was detected for EXBID in comparison with EXQW (WMD=‐0.73, 95% CI [-1.13, -0.33], P=0.001), and no significant difference was found between EXQW and MET. Conclusions. EXQW shows a greater improvement in HOMA-β than EXBID. Moreover, the efficacy of EXQW on glycemic control is similar to other antidiabetic agents including EXBID. It is an advisable treatment for diabetic patients to improve HOMA-β and has an advantage of fewer number of injections compared with EXBID, to increase patients’ adherence and quality of life. |
| format | Article |
| id | doaj-art-1b3667d75885409da1c0eee6fa68b2f9 |
| institution | Kabale University |
| issn | 2314-6745 2314-6753 |
| language | English |
| publishDate | 2019-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Journal of Diabetes Research |
| spelling | doaj-art-1b3667d75885409da1c0eee6fa68b2f92025-02-03T06:05:10ZengWileyJournal of Diabetes Research2314-67452314-67532019-01-01201910.1155/2019/80834178083417The Effects of Exenatide Once Weekly (EXQW) and Exenatide Twice a Day (EXBID) on Beta-Cell Function in Type 2 Diabetes: A Systematic Review and Network Meta-AnalysisJie Wang0Xinye Jin1Ping An2Songyan Yu3Yiming Mu4Medicine School of Nankai University, ChinaDepartment of Endocrinology, Chinese PLA General Hospital, Beijing, ChinaDepartment of Endocrinology, Chinese PLA General Hospital, Beijing, ChinaMedicine School of Nankai University, ChinaMedicine School of Nankai University, ChinaBackground. In patients with type 2 diabetes mellitus (T2DM) and poor glycemic control receiving metformin (MET), glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are recommended as the adjunctive therapy. However, there are only a few studies involving the comparative effects of exenatide twice a day (EXBID) and exenatide once weekly (EXQW) on HOMA-β. This meta assessed the comparative effects of EXQW and EXBID on HOMA-β among T2DM patients. Materials and Methods. PubMed, Cochrane Library, and Embase databases were searched to collect randomized controlled trials (RCTs). Network meta-analysis was performed, and network diagrams were constructed to evaluate the effects. The primary outcome is HOMA-β, and the secondary outcomes are fasting blood glycose (FBG), glycated hemoglobin (HbA1c), and weight loss. Results. A total of 8 studies with 3506 subjects were included. Compared with other antidiabetic agents, EXQW has a greater improvement in HOMA-β than EXBID (weight mean difference WMD=‐0.46, 95% confidence interval (CI) [-0.64, -0.28], P=0.001). The effect of EXQW on HbA1c is superior to that of sitagliptin (SITA) (WMD=0.51, 95% CI [0.03, 0.99], P=0.037). The significant reduction of weight was detected for EXBID in comparison with EXQW (WMD=‐0.73, 95% CI [-1.13, -0.33], P=0.001), and no significant difference was found between EXQW and MET. Conclusions. EXQW shows a greater improvement in HOMA-β than EXBID. Moreover, the efficacy of EXQW on glycemic control is similar to other antidiabetic agents including EXBID. It is an advisable treatment for diabetic patients to improve HOMA-β and has an advantage of fewer number of injections compared with EXBID, to increase patients’ adherence and quality of life.http://dx.doi.org/10.1155/2019/8083417 |
| spellingShingle | Jie Wang Xinye Jin Ping An Songyan Yu Yiming Mu The Effects of Exenatide Once Weekly (EXQW) and Exenatide Twice a Day (EXBID) on Beta-Cell Function in Type 2 Diabetes: A Systematic Review and Network Meta-Analysis Journal of Diabetes Research |
| title | The Effects of Exenatide Once Weekly (EXQW) and Exenatide Twice a Day (EXBID) on Beta-Cell Function in Type 2 Diabetes: A Systematic Review and Network Meta-Analysis |
| title_full | The Effects of Exenatide Once Weekly (EXQW) and Exenatide Twice a Day (EXBID) on Beta-Cell Function in Type 2 Diabetes: A Systematic Review and Network Meta-Analysis |
| title_fullStr | The Effects of Exenatide Once Weekly (EXQW) and Exenatide Twice a Day (EXBID) on Beta-Cell Function in Type 2 Diabetes: A Systematic Review and Network Meta-Analysis |
| title_full_unstemmed | The Effects of Exenatide Once Weekly (EXQW) and Exenatide Twice a Day (EXBID) on Beta-Cell Function in Type 2 Diabetes: A Systematic Review and Network Meta-Analysis |
| title_short | The Effects of Exenatide Once Weekly (EXQW) and Exenatide Twice a Day (EXBID) on Beta-Cell Function in Type 2 Diabetes: A Systematic Review and Network Meta-Analysis |
| title_sort | effects of exenatide once weekly exqw and exenatide twice a day exbid on beta cell function in type 2 diabetes a systematic review and network meta analysis |
| url | http://dx.doi.org/10.1155/2019/8083417 |
| work_keys_str_mv | AT jiewang theeffectsofexenatideonceweeklyexqwandexenatidetwiceadayexbidonbetacellfunctionintype2diabetesasystematicreviewandnetworkmetaanalysis AT xinyejin theeffectsofexenatideonceweeklyexqwandexenatidetwiceadayexbidonbetacellfunctionintype2diabetesasystematicreviewandnetworkmetaanalysis AT pingan theeffectsofexenatideonceweeklyexqwandexenatidetwiceadayexbidonbetacellfunctionintype2diabetesasystematicreviewandnetworkmetaanalysis AT songyanyu theeffectsofexenatideonceweeklyexqwandexenatidetwiceadayexbidonbetacellfunctionintype2diabetesasystematicreviewandnetworkmetaanalysis AT yimingmu theeffectsofexenatideonceweeklyexqwandexenatidetwiceadayexbidonbetacellfunctionintype2diabetesasystematicreviewandnetworkmetaanalysis AT jiewang effectsofexenatideonceweeklyexqwandexenatidetwiceadayexbidonbetacellfunctionintype2diabetesasystematicreviewandnetworkmetaanalysis AT xinyejin effectsofexenatideonceweeklyexqwandexenatidetwiceadayexbidonbetacellfunctionintype2diabetesasystematicreviewandnetworkmetaanalysis AT pingan effectsofexenatideonceweeklyexqwandexenatidetwiceadayexbidonbetacellfunctionintype2diabetesasystematicreviewandnetworkmetaanalysis AT songyanyu effectsofexenatideonceweeklyexqwandexenatidetwiceadayexbidonbetacellfunctionintype2diabetesasystematicreviewandnetworkmetaanalysis AT yimingmu effectsofexenatideonceweeklyexqwandexenatidetwiceadayexbidonbetacellfunctionintype2diabetesasystematicreviewandnetworkmetaanalysis |